Gerbicvet (Syrup) Instructions for Use
Marketing Authorization Holder
Ivanovo Pharmaceutical Factory PJSC (Russia)
ATC Code
R05CA10 (Expectorants in combination)
Active Substances
Thyme (Ph.Eur. European Pharmacopoeia)
Primulae radix (DAB German Pharmacopoeia)
Dosage Form
| Gerbicvet | Syrup: jar or bottle 50 ml, 60 ml, 100 ml, 130 ml, 150 ml, or 200 ml |
Dosage Form, Packaging, and Composition
Syrup brown in color with a characteristic odor; opalescence is allowed.
| 1 ml | |
| Liquid extract of primrose rhizomes with roots | 0.206 g |
| Common thyme herb liquid extract | 0.412 g |
Excipients: levomenthol, methylparahydroxybenzoate, sucrose.
50 ml – orange glass jars (1) – cardboard packs.
60 ml – orange glass jars (1) – cardboard packs.
100 ml – orange glass jars (1) – cardboard packs.
130 ml – orange glass jars (1) – cardboard packs.
200 ml – orange glass jars (1) – cardboard packs.
50 ml – brown glass bottles (1) – cardboard packs.
60 ml – brown glass bottles (1) – cardboard packs.
100 ml – brown glass bottles (1) – cardboard packs.
130 ml – brown glass bottles (1) – cardboard packs.
150 ml – brown glass bottles (1) – cardboard packs.
200 ml – brown glass bottles (1) – cardboard packs.
Clinical-Pharmacological Group
Herbal preparation with expectorant effect
Pharmacotherapeutic Group
Drugs used for cough and colds; expectorants, excluding combinations with antitussives; expectorants
Pharmacological Action
Herbal medicine. It has expectorant, anti-inflammatory, antimicrobial action, helps to reduce the viscosity of sputum and improve sputum discharge.
Indications
As an expectorant in the complex therapy of: inflammatory diseases of the respiratory tract accompanied by cough with difficult-to-discharge sputum (including bronchitis, tracheitis, tracheobronchitis); for acute respiratory diseases accompanied by a dry cough.
ICD codes
| ICD-10 code | Indication |
| J04 | Acute laryngitis and tracheitis |
| J06.9 | Acute upper respiratory infection, unspecified |
| J20 | Acute bronchitis |
| J37 | Chronic laryngitis and laryngotracheitis |
| J42 | Unspecified chronic bronchitis |
| R05 | Cough |
| ICD-11 code | Indication |
| CA05 | Acute laryngitis or tracheitis |
| CA07.0 | Acute upper respiratory tract infection of unspecified site |
| CA0G | Chronic laryngitis or laryngotracheitis |
| CA20.1Z | Chronic bronchitis, unspecified |
| CA42.Z | Acute bronchitis, unspecified |
| MD12 | Cough |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Administer the syrup orally. Shake the bottle well before each use.
Adhere to the following dosing schedule three to four times daily.
For adults and adolescents aged 14 years and older: take 5 ml to 7.5 ml per dose.
For school-age children from 6 to 13 years: take 2.5 ml to 5 ml per dose.
For young children from 2 to 5 years: take 2.5 ml per dose.
Use the measuring cup supplied with the package for accurate dosing.
The standard course of treatment is two to three weeks.
Do not exceed the recommended duration without medical supervision.
Consult a physician to extend treatment or for a repeat course of therapy.
Adverse Reactions
Possible allergic reactions.
Rarely nausea, vomiting, diarrhea.
Contraindications
Children after acute obstructive laryngitis (croup); bronchial asthma; diabetes mellitus; hereditary fructose intolerance; children under 2 years of age; hypersensitivity to the components of the combination, as well as to drugs containing active substances of plants of the Primulaceae family and the Lamiaceae family.
Use in Pregnancy and Lactation
It is not recommended to use the drug for pregnant and breastfeeding women (due to insufficient data on the safety of the drug in this category of patients).
Pediatric Use
Contraindicated for use in children after acute obstructive laryngitis (croup) and under the age of 2 years.
Special Precautions
If side effects occur, the patient should stop taking the medicine and consult a doctor.
Drug Interactions
Should not be used simultaneously with antitussive drugs and drugs that reduce sputum formation, as this makes it difficult to cough up liquefied sputum.
Storage Conditions
Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.
Dispensing Status
Over-the-Counter
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical Disclaimer